HeyJaredRoss Law
- Indexed articles, last 90 days
- 33
- Latest publication
- Sep 3, 2026
- Outlet visibility, for Hospital Management
- Top 10M sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Podcast: A Q4 preview from Medical Device Network (opens the original)
Read excerpt
Summer is officially behind us and we're turning our attention to Q4. Here's a sneak peek of what we have coming up over the coming months. The latest issue of the Medical Device Developments (MDD) magazine is due to appear in print and online in late October. In this edition, we focus on topics including the final countdown to the EU's medical device regulation, the role AI is playing in medical device manufacturing, how smart packaging technology is becoming a strategic lever in medtech compan
Elucid raises $55m to advance cardiovascular diagnostic portfolio (opens the original)
Read excerpt
Elucid has raised $55m to further develop its artificial intelligence (AI)-based cardiovascular imaging platform and support preparations for the anticipated US Food and Drug Administration (FDA) clearance of its fractional flow reserve (FFR)-CT software. Bringing its total funding to date to around $185m, the Boston-based company's oversubscribed Series D financing round included participation from new and existing investors, including IAG Capital Partners and Elevage Medical Technologies. Eluc
Medtronic raises FY27 outlook after reporting strong Q1 growth (opens the original)
Read excerpt
Medtronic has reported revenues of around $9.8bn in Q1 of fiscal year 2027 (FY27) driven by double-digit growth across its key business segments, prompting the company to raise its FY27 outlook. With Q1 performance corresponding to year-over-year (YoY) growth of 13.7%, the medtech giant now expects organic revenue growth for FY27 to land in the 7.25% to 7.75% range, up from 6.75% to 7.25% previously, and with earnings anticipated to come in at $5.94-$6 per share versus $5.90-$6 previously. Medtr
Guardant ordered to pay $245m in DNA sequencing patent dispute (opens the original)
Read excerpt
A US court has ordered Guardant Health to pay TwinStrand Biosciences and the University of Washington (UW) $245.2m after upholding a November 2023 jury verdict that found the company liable for infringing on patented DNA sequencing technologies. The US District Court of Columbia's judgement ends a complaint TwinStrand filed in August 2021, asserting that Guardant infringed on two core patents underlying TwinStrand's and UW's Duplex Sequencing technology. Duplex Sequencing is a form of next-gener
Expressable joins Amazon’s Health Benefits Connector for speech therapy provision (opens the original)
Read excerpt
Expressable has joined Amazon's Health Benefits Connector, becoming the first speech therapy services provider to join the platform. Acting as a bridge between customers and virtual-care providers, Amazon's connector is part of the e-commerce giant's broader healthcare ecosystem and is intended to help US customers discover and make use of health benefits that are potentially already available through their employer or insurer. Expressable's service pairs clients with licensed, insurance-covered
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 10M sites
For Hospital Management, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.